共 50 条
- [1] CUTANEOUS LEISHMANIASIS - TREATMENT WITH CRYOTHERAPY AND INTRAMUSCULAR INJECTIONS OF MEGLUMINE ANTIMONATE (GLUCANTIME) [J]. HAUTARZT, 1990, 41 (02): : 98 - 101
- [2] Safety profile of parenteral meglumine antimoniate (Glucantime®) in infants treated for cutaneous leishmaniasis [J]. THERAPIE, 2020, 75 (03): : 314 - 316
- [5] PLACEBO-CONTROLLED CLINICAL-TRIAL OF MEGLUMINE ANTIMONATE (GLUCANTIME) VS LOCALIZED CONTROLLED HEAT IN THE TREATMENT OF CUTANEOUS LEISHMANIASIS IN GUATEMALA [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1990, 42 (01): : 43 - 50
- [8] Intralesional Metronidazole (5%) VS Intralesional Meglumine Antimonate in Cutaneous Leishmaniasis [J]. ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN, 2022, 28 (02): : 180 - 187
- [9] Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (01): : 99 - 101
- [10] Efficacy of Cryotherapy versus Intralesional Meglumine Antimoniate (Glucantime) for Treatment of Cutaneous Leishmaniasis in Children [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 80 (02): : 172 - 175